View More Recent Stories

Aug 13, 2024 07:05AM Dynegy (DYN) Tops Q2 EPS by 2c

Aug 13, 2024 06:43AM Dyne Therapeutics (DYN) PT Raised to $55 at H.C. Wainwright

Aug 13, 2024 06:39AM Oppenheimer Reiterates Outperform Rating on Dyne Therapeutics (DYN)

Jun 24, 2024 12:31PM Jefferies Reiterates Buy Rating on Dyne Therapeutics (DYN)

Jun 24, 2024 07:32AM Dyne Therapeutics (DYN) Presents New Preclinical Data Demonstrating the Potential of the FORCE Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease

Jun 17, 2024 07:25AM Oppenheimer Reiterates Outperform Rating on Dyne Therapeutics (DYN)

View More Recent Stories